Royal Marsden Nhs Foundation Trust

This study follows 200 adults with solid tumors who are starting immunotherapy (checkpoint inhibitors). Researchers collect blood and tissue samples before and during treatment to understand why some patients develop immune-related side effects. The goal is to find early warning …